Review



sheep anti erbb3 r d systems  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems sheep anti erbb3 r d systems
    Sheep Anti Erbb3 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sheep anti erbb3 r d systems/product/R&D Systems
    Average 93 stars, based on 10 article reviews
    sheep anti erbb3 r d systems - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems sheep anti erbb3 r d systems
    Sheep Anti Erbb3 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sheep anti erbb3 r d systems/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    sheep anti erbb3 r d systems - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    88
    R&D Systems human erbb3 duoset elisa r d systems
    Human Erbb3 Duoset Elisa R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human erbb3 duoset elisa r d systems/product/R&D Systems
    Average 88 stars, based on 1 article reviews
    human erbb3 duoset elisa r d systems - by Bioz Stars, 2026-03
    88/100 stars
      Buy from Supplier

    93
    R&D Systems erbb3 r d systems
    Erbb3 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/erbb3 r d systems/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    erbb3 r d systems - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    95
    R&D Systems quantikine human immunoassay r d system
    Quantikine Human Immunoassay R D System, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quantikine human immunoassay r d system/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    quantikine human immunoassay r d system - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    R&D Systems quantikine human immunoassay r d systems
    FIGURE 4. Involvement of VEGF in STAT3 activation under hypoxia and relationship with JAK/STAT3 pathway. A, IGR-Heu tumor cells were kept under normoxia (21% PO2) and hypoxia (1% PO2) for 24 h. ELISA was performed for quantification of IL-6, IL-10, and VEGF by <t>Quantikine</t> Human <t>immunoassay</t> R&D Systems. Bars, SD. The results shown are representative of two independent experiments. B, IGR-Heu tumor cells were incubated for 24 h with 25, 50, and 100 g/ml Avastin (Genentech) or an isotype control Ab (human IgG1; Sigma-Aldrich) in reduced serum conditions (0.5% FBS) under (21% PO2) and hypoxia (1% PO2). Whole-cell lysates (30 g) were subjected to SDS-PAGE, blotted, and probed with Abs, as indicated. Actin was used as the loading control. C, Attenuation of IGR-Heu tumor cells resistance to CTL (Heu171)-mediated lysis under hypoxic conditions following treatment with anti-VEGF (Avastin). IGR-Heu tumor cells were incubated for 24 h with 25 g/ml Avastin or an isotype control Ab (human IgG1; Sigma-Aldric h) under normoxia (21% PO2) and hypoxia (1% PO2). Cytotoxicity was determined by a conventional 4-h 51Cr release assay. Heu171 (TIL-derived T cell clone) was used as effectors. Bars, SD.
    Quantikine Human Immunoassay R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quantikine human immunoassay r d systems/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    quantikine human immunoassay r d systems - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    R&D Systems quantikine human immunoassay kits r d systems
    FIGURE 4. Involvement of VEGF in STAT3 activation under hypoxia and relationship with JAK/STAT3 pathway. A, IGR-Heu tumor cells were kept under normoxia (21% PO2) and hypoxia (1% PO2) for 24 h. ELISA was performed for quantification of IL-6, IL-10, and VEGF by <t>Quantikine</t> Human <t>immunoassay</t> R&D Systems. Bars, SD. The results shown are representative of two independent experiments. B, IGR-Heu tumor cells were incubated for 24 h with 25, 50, and 100 g/ml Avastin (Genentech) or an isotype control Ab (human IgG1; Sigma-Aldrich) in reduced serum conditions (0.5% FBS) under (21% PO2) and hypoxia (1% PO2). Whole-cell lysates (30 g) were subjected to SDS-PAGE, blotted, and probed with Abs, as indicated. Actin was used as the loading control. C, Attenuation of IGR-Heu tumor cells resistance to CTL (Heu171)-mediated lysis under hypoxic conditions following treatment with anti-VEGF (Avastin). IGR-Heu tumor cells were incubated for 24 h with 25 g/ml Avastin or an isotype control Ab (human IgG1; Sigma-Aldric h) under normoxia (21% PO2) and hypoxia (1% PO2). Cytotoxicity was determined by a conventional 4-h 51Cr release assay. Heu171 (TIL-derived T cell clone) was used as effectors. Bars, SD.
    Quantikine Human Immunoassay Kits R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/quantikine human immunoassay kits r d systems/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    quantikine human immunoassay kits r d systems - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    Image Search Results


    FIGURE 4. Involvement of VEGF in STAT3 activation under hypoxia and relationship with JAK/STAT3 pathway. A, IGR-Heu tumor cells were kept under normoxia (21% PO2) and hypoxia (1% PO2) for 24 h. ELISA was performed for quantification of IL-6, IL-10, and VEGF by Quantikine Human immunoassay R&D Systems. Bars, SD. The results shown are representative of two independent experiments. B, IGR-Heu tumor cells were incubated for 24 h with 25, 50, and 100 g/ml Avastin (Genentech) or an isotype control Ab (human IgG1; Sigma-Aldrich) in reduced serum conditions (0.5% FBS) under (21% PO2) and hypoxia (1% PO2). Whole-cell lysates (30 g) were subjected to SDS-PAGE, blotted, and probed with Abs, as indicated. Actin was used as the loading control. C, Attenuation of IGR-Heu tumor cells resistance to CTL (Heu171)-mediated lysis under hypoxic conditions following treatment with anti-VEGF (Avastin). IGR-Heu tumor cells were incubated for 24 h with 25 g/ml Avastin or an isotype control Ab (human IgG1; Sigma-Aldric h) under normoxia (21% PO2) and hypoxia (1% PO2). Cytotoxicity was determined by a conventional 4-h 51Cr release assay. Heu171 (TIL-derived T cell clone) was used as effectors. Bars, SD.

    Journal: Journal of immunology (Baltimore, Md. : 1950)

    Article Title: The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

    doi: 10.4049/jimmunol.0800854

    Figure Lengend Snippet: FIGURE 4. Involvement of VEGF in STAT3 activation under hypoxia and relationship with JAK/STAT3 pathway. A, IGR-Heu tumor cells were kept under normoxia (21% PO2) and hypoxia (1% PO2) for 24 h. ELISA was performed for quantification of IL-6, IL-10, and VEGF by Quantikine Human immunoassay R&D Systems. Bars, SD. The results shown are representative of two independent experiments. B, IGR-Heu tumor cells were incubated for 24 h with 25, 50, and 100 g/ml Avastin (Genentech) or an isotype control Ab (human IgG1; Sigma-Aldrich) in reduced serum conditions (0.5% FBS) under (21% PO2) and hypoxia (1% PO2). Whole-cell lysates (30 g) were subjected to SDS-PAGE, blotted, and probed with Abs, as indicated. Actin was used as the loading control. C, Attenuation of IGR-Heu tumor cells resistance to CTL (Heu171)-mediated lysis under hypoxic conditions following treatment with anti-VEGF (Avastin). IGR-Heu tumor cells were incubated for 24 h with 25 g/ml Avastin or an isotype control Ab (human IgG1; Sigma-Aldric h) under normoxia (21% PO2) and hypoxia (1% PO2). Cytotoxicity was determined by a conventional 4-h 51Cr release assay. Heu171 (TIL-derived T cell clone) was used as effectors. Bars, SD.

    Article Snippet: A, IGR-Heu tumor cells were kept under normoxia (21% PO2) and hypoxia (1% PO2) for 24 h. ELISA was performed for quantification of IL-6, IL-10, and VEGF by Quantikine Human immunoassay R&D Systems.

    Techniques: Activation Assay, Enzyme-linked Immunosorbent Assay, Incubation, Control, SDS Page, Lysis, Release Assay, Derivative Assay